FIELD: medicine. SUBSTANCE: method involves injecting Klebsiella lipopolysaccharide into renal tissue of an experimental animal (white rat) at a dose of 1.75 mcg (1.0 ml). Lipopolysaccharide at a resolving dose of 17.5 mcg (1.0 ml) and Escherichia coli strain suspension taken from a pyelonephritis patient are intravenously injected 24 h later. EFFECT: stable reproducibility of modeling results; low costs. 3 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR SIMULATING GESTATIONAL PYELONEPHRITIS | 2013 |
|
RU2532402C1 |
METHOD OF MODELING PYELONEPHRITIS | 0 |
|
SU1617455A1 |
METHOD FOR SIMULATING NON-OBSTRUCTIVE PIEOLNEPHRITIS | 0 |
|
SU1097633A1 |
METHOD OF ACUTE PYELONEPHRITIS MODELLING | 2007 |
|
RU2349965C1 |
METHOD FOR SIMULATING ACUTE PYELONEPHRITIS WITH UNDERLYING CRYOGENIC EFFECT | 2008 |
|
RU2387019C2 |
METHOD OF ACUTE PYELONEPHRITIS SIMULATION WITH UNDERLYING COLD STRESS | 2008 |
|
RU2368016C1 |
METHOD OF MODULATING POST-TRANSPLANTATION CHANGING IN KIDNEYS | 2014 |
|
RU2557701C1 |
METHOD FOR SIMULATING CHRONIC MEMBRANOUS GLOMERULONEPHRITIS IN EXPERIMENT | 2008 |
|
RU2373583C1 |
METHOD FOR MODELING PYELONEPHRITIS | 2004 |
|
RU2289852C2 |
METHOD OF TREATING ACUTE POSTSTREPTOCOCCAL GLOMERULONEPHRITIS IN EXPERIMENT | 2009 |
|
RU2393547C1 |
Authors
Dates
2000-05-20—Published
1999-07-07—Filed